With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO

With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO

Source: 
Fierce Pharma
snippet: 

Since its massive Shire acquisition in 2019, Takeda has been focused on paying off tens of billions in debt. But since it's leaned on asset sales to gin up cash, skeptics had begun wondering whether the company could meet its debt payment goals in the long run.